TLRY

Tilray Brands, Inc. | Healthcare

-2.04082%

Analisi Pre-Earnings (Antonio AI)

2025-12-18
Sentiment
95.0/100
Salute

Caution

Verdict

Pure political hype is driving a euphoric run-up into earnings. 🔥 But with zero visibility into the company's financials, this is a dangerous gamble, not a calculated trade. ⚠️

Catalysts
  • Potential US federal reclassification of cannabis via executive order.
  • Massive speculative momentum and retail interest.
Rischi
  • The company's health is a complete unknown; it could be a cash-burning machine on the verge of dilution. The primary health filter failed.
Approfondisci con Antonio
Valutazione
P/E (TTM)-0.3270955346614817
Forward P/E-0.3270955346614817
P/S0.960771568434276
Market Cap806241686
Finanze & Debito
CashNone
DebtNone
Debt/Equity0.15011718372239888
Current Ratio2.6197913552938363
Redditività
ROE-0.9686378632820482
Profit Margin-2.7811859458619708
Operating Margin-2.901035870072616
Rev. Growth0.27259871404572517
Ultime News (Context per AI)